US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist

0.305
-0.001-0.16%

Close Nov 25 16:00 ET

0.300
-0.005-1.51%

Post 20:01 ET

16.71MMarket Cap-174P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

28.82%-13.98M

39.17%-12.44M

12.03%-30.45M

-16.95%-92.08M

26.12%-17.37M

22.02%-19.65M

-354.03%-20.45M

-35.62%-34.62M

-31.03%-78.73M

-1,788.35%-23.51M

Net income from continuing operations

55.49%-12.48M

36.41%-20.02M

-15.12%-30.7M

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

Depreciation and amortization

23.73%73K

28.33%77K

-27.59%42K

4.44%259K

34.43%82K

-3.28%59K

-4.76%60K

-7.94%58K

0.00%248K

-1.61%61K

Other non cash items

376.41%2.2M

464.06%2.17M

500.27%2.25M

88.40%2.68M

297.28%1.46M

28.33%462K

9.40%384K

9.01%375K

8.88%1.42M

8.90%367K

Change In working capital

-327.94%-10.57M

-69.92%2.14M

58.05%-4.89M

178.67%10.17M

255.22%10.07M

177.57%4.64M

226.87%7.11M

-178.66%-11.65M

-345.56%-12.92M

-87.51%2.83M

-Change in receivables

-91.82%451K

127.64%1.1M

139.07%1.1M

113.21%436K

-72.89%1.71M

443.79%5.51M

28.07%-3.98M

-13.15%-2.81M

-461.95%-3.3M

-68.24%6.32M

-Change in inventory

-100.65%-1K

-512.63%-392K

107.07%80K

-317.91%-438K

181.20%445K

-90.52%154K

106.12%95K

-267.21%-1.13M

107.78%201K

78.79%-548K

-Change in prepaid assets

-39.82%1.4M

-9.28%2.01M

354.74%2.36M

159.01%8.11M

96.25%4.5M

118.49%2.32M

343.04%2.22M

64.23%-928K

-243.85%-13.75M

-38.62%2.3M

-Change in payables and accrued expense

-177.67%-8.05M

-110.28%-951K

-60.67%-10.15M

-42.33%3.28M

167.80%3.24M

-141.49%-2.9M

226.85%9.25M

-1,087.19%-6.32M

656.76%5.68M

-333.09%-4.78M

-Change in other current liabilities

-1,175.73%-4.36M

--0

-9.29%-1.92M

-40.66%-640K

23.15%-342K

-9.72%-474K

-9.22%-462K

-9.55%-1.76M

-9.38%-455K

-Change in other working capital

--0

--368K

--1.73M

--699K

--807K

----

Cash from discontinued investing activities

Operating cash flow

28.82%-13.98M

39.17%-12.44M

12.03%-30.45M

-16.95%-92.08M

26.12%-17.37M

22.02%-19.65M

-354.03%-20.45M

-35.62%-34.62M

-31.03%-78.73M

-1,788.35%-23.51M

Investing cash flow

Cash flow from continuing investing activities

-89.20%2.5M

-53.39%15.29M

46.55%25.95M

-66.23%43.46M

-167.99%-30.21M

9.35%23.16M

10.53%32.8M

-47.03%17.71M

2,809.05%128.71M

182.91%44.42M

Net PPE purchase and sale

--0

---210K

---836K

-5,423.26%-2.38M

---2.05M

---323K

--0

-238.71%-43K

--0

Net investment purchase and sale

-89.35%2.5M

-52.75%15.5M

51.27%26.79M

-64.40%45.84M

-163.37%-28.15M

10.87%23.48M

10.53%32.8M

-47.10%17.71M

2,792.39%128.75M

182.97%44.42M

Cash from discontinued investing activities

Investing cash flow

-89.20%2.5M

-53.39%15.29M

46.55%25.95M

-66.23%43.46M

-167.99%-30.21M

9.35%23.16M

10.53%32.8M

-47.03%17.71M

2,809.05%128.71M

182.91%44.42M

Financing cash flow

Cash flow from continuing financing activities

-162.19%-694K

-610K

-222.32%-685K

12,167.20%38.15M

165,695.45%36.48M

973.08%1.12M

18,566.67%560K

-99.33%311K

-99.95%22K

Net common stock issuance

----

--1.12M

--0

----

--0

Proceeds from stock option exercised by employees

--0

80.06%560K

-95.45%1K

-100.96%-1K

--0

18,566.67%560K

-81.03%311K

-93.10%22K

Net other financing activities

---694K

---610K

---685K

--36.47M

----

Cash from discontinued financing activities

Financing cash flow

-162.19%-694K

---610K

-222.32%-685K

12,167.20%38.15M

165,695.45%36.48M

973.08%1.12M

--0

18,566.67%560K

-99.33%311K

-99.95%22K

Net cash flow

Beginning cash position

-15.66%50.74M

1.46%48.5M

-16.32%53.68M

362.80%64.15M

49.91%64.78M

27.65%60.16M

119.56%47.8M

362.80%64.15M

-56.81%13.86M

84.68%43.21M

Current changes in cash

-363.25%-12.18M

-81.85%2.24M

68.28%-5.19M

-120.81%-10.47M

-153.02%-11.1M

218.25%4.63M

-51.26%12.36M

-306.73%-16.35M

375.85%50.29M

319.49%20.94M

End cash Position

-40.48%38.56M

-15.66%50.74M

1.46%48.5M

-16.32%53.68M

49.91%64.78M

27.65%60.16M

119.56%47.8M

362.80%64.15M

Free cash flow

29.97%-13.98M

38.14%-12.65M

9.62%-31.29M

-19.91%-94.45M

17.39%-19.42M

20.74%-19.97M

-354.03%-20.45M

-35.40%-34.62M

-31.01%-78.77M

-1,731.00%-23.51M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	28.82%-13.98M	39.17%-12.44M	12.03%-30.45M	-16.95%-92.08M	26.12%-17.37M	22.02%-19.65M	-354.03%-20.45M	-35.62%-34.62M	-31.03%-78.73M	-1,788.35%-23.51M
Net income from continuing operations	55.49%-12.48M	36.41%-20.02M	-15.12%-30.7M	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M
Depreciation and amortization	23.73%73K	28.33%77K	-27.59%42K	4.44%259K	34.43%82K	-3.28%59K	-4.76%60K	-7.94%58K	0.00%248K	-1.61%61K
Other non cash items	376.41%2.2M	464.06%2.17M	500.27%2.25M	88.40%2.68M	297.28%1.46M	28.33%462K	9.40%384K	9.01%375K	8.88%1.42M	8.90%367K
Change In working capital	-327.94%-10.57M	-69.92%2.14M	58.05%-4.89M	178.67%10.17M	255.22%10.07M	177.57%4.64M	226.87%7.11M	-178.66%-11.65M	-345.56%-12.92M	-87.51%2.83M
-Change in receivables	-91.82%451K	127.64%1.1M	139.07%1.1M	113.21%436K	-72.89%1.71M	443.79%5.51M	28.07%-3.98M	-13.15%-2.81M	-461.95%-3.3M	-68.24%6.32M
-Change in inventory	-100.65%-1K	-512.63%-392K	107.07%80K	-317.91%-438K	181.20%445K	-90.52%154K	106.12%95K	-267.21%-1.13M	107.78%201K	78.79%-548K
-Change in prepaid assets	-39.82%1.4M	-9.28%2.01M	354.74%2.36M	159.01%8.11M	96.25%4.5M	118.49%2.32M	343.04%2.22M	64.23%-928K	-243.85%-13.75M	-38.62%2.3M
-Change in payables and accrued expense	-177.67%-8.05M	-110.28%-951K	-60.67%-10.15M	-42.33%3.28M	167.80%3.24M	-141.49%-2.9M	226.85%9.25M	-1,087.19%-6.32M	656.76%5.68M	-333.09%-4.78M
-Change in other current liabilities	-1,175.73%-4.36M	--0	--0	-9.29%-1.92M	-40.66%-640K	23.15%-342K	-9.72%-474K	-9.22%-462K	-9.55%-1.76M	-9.38%-455K
-Change in other working capital	--0	--368K	--1.73M	--699K	--807K	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	28.82%-13.98M	39.17%-12.44M	12.03%-30.45M	-16.95%-92.08M	26.12%-17.37M	22.02%-19.65M	-354.03%-20.45M	-35.62%-34.62M	-31.03%-78.73M	-1,788.35%-23.51M
Investing cash flow
Cash flow from continuing investing activities	-89.20%2.5M	-53.39%15.29M	46.55%25.95M	-66.23%43.46M	-167.99%-30.21M	9.35%23.16M	10.53%32.8M	-47.03%17.71M	2,809.05%128.71M	182.91%44.42M
Net PPE purchase and sale	--0	---210K	---836K	-5,423.26%-2.38M	---2.05M	---323K	--0	--0	-238.71%-43K	--0
Net investment purchase and sale	-89.35%2.5M	-52.75%15.5M	51.27%26.79M	-64.40%45.84M	-163.37%-28.15M	10.87%23.48M	10.53%32.8M	-47.10%17.71M	2,792.39%128.75M	182.97%44.42M
Cash from discontinued investing activities
Investing cash flow	-89.20%2.5M	-53.39%15.29M	46.55%25.95M	-66.23%43.46M	-167.99%-30.21M	9.35%23.16M	10.53%32.8M	-47.03%17.71M	2,809.05%128.71M	182.91%44.42M
Financing cash flow
Cash flow from continuing financing activities	-162.19%-694K	-610K	-222.32%-685K	12,167.20%38.15M	165,695.45%36.48M	973.08%1.12M	0	18,566.67%560K	-99.33%311K	-99.95%22K
Net common stock issuance	----	----	----	--1.12M	--0	----	----	----	--0	--0
Proceeds from stock option exercised by employees	--0	--0	--0	80.06%560K	-95.45%1K	-100.96%-1K	--0	18,566.67%560K	-81.03%311K	-93.10%22K
Net other financing activities	---694K	---610K	---685K	--36.47M	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-162.19%-694K	---610K	-222.32%-685K	12,167.20%38.15M	165,695.45%36.48M	973.08%1.12M	--0	18,566.67%560K	-99.33%311K	-99.95%22K
Net cash flow
Beginning cash position	-15.66%50.74M	1.46%48.5M	-16.32%53.68M	362.80%64.15M	49.91%64.78M	27.65%60.16M	119.56%47.8M	362.80%64.15M	-56.81%13.86M	84.68%43.21M
Current changes in cash	-363.25%-12.18M	-81.85%2.24M	68.28%-5.19M	-120.81%-10.47M	-153.02%-11.1M	218.25%4.63M	-51.26%12.36M	-306.73%-16.35M	375.85%50.29M	319.49%20.94M
End cash Position	-40.48%38.56M	-15.66%50.74M	1.46%48.5M	-16.32%53.68M	-16.32%53.68M	49.91%64.78M	27.65%60.16M	119.56%47.8M	362.80%64.15M	362.80%64.15M
Free cash flow	29.97%-13.98M	38.14%-12.65M	9.62%-31.29M	-19.91%-94.45M	17.39%-19.42M	20.74%-19.97M	-354.03%-20.45M	-35.40%-34.62M	-31.01%-78.77M	-1,731.00%-23.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data